Skip to main content
Log in

Discriminative stimulus properties of muscarinic agonists

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In a two-lever, food-reinforced drug-discrimination paradigm separate groups of rats were trained to discriminate either arecoline, pilocarpine or oxotremorine from saline. The discriminative cues of all three agonists were potently blocked by scopolamine, but only by 30–60 fold higher doses of methylscopolamine. The three agonists all suppressed overall response rate. These rate-suppressant effects were not blocked by scopolamine in doses which blocked the discriminative cues. In generalization tests, arecoline elicited selection of the drug-appropriate lever in all groups of trained animals. Pilocarpine was discriminated as drug by all pilocarpine-trained animals and by a majority of oxotremorine-trained animals, but was not significantly discriminated by the arecoline-trained group. Oxotremorine was discriminated by all oxotremorine-trained animals but only by some pilocarpine-trained animals, and was not significantly discriminated by the arecoline-trained group. Morphine, haloperidol, chlordiazepoxide, pentobarbital and nicotine were not generalized to any of the training drugs. The discriminative stimuli produced by the training drugs are therefore specific and exhibit properties indicative of an origin at central muscarinic receptors but may not be identical.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ahlenius S, Larsson K (1985) Central muscarinic receptors and male rat sexual behavior: facilitation by oxotremorine but not arecoline or pilocarpine in methscopolamine pretreated animals. Psychopharmacology 87:127–129

    Google Scholar 

  • Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459–496

    Google Scholar 

  • Bowen DM, Benton JS, Spillane JA, Smith CCT, Allen SJ (1982) Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57:191–202

    Google Scholar 

  • Brinkman SD, Gershon S (1983) Measurement of cholinergic drug effects on memory in Alzheimer's disease. Neurobiol Aging 4:139–145

    Google Scholar 

  • Chance WT, Murfin D, Krynock GM, Rosecrans JA (1977) A description of the nicotine stimulus and tests of its generalization to amphetamine. Psychopharmacology 55:19–26

    Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1975) The narcotic cue: evidence for the specificity of the stimulus properties of narcotic drugs. Arch Int Pharmacodyn Ther 218:268–276

    Google Scholar 

  • Colpaert FC, Rosecrans JA (1978) Stimulus properties of drugs: 10 years of progress. Elsevier North Holland, Amsterdam

    Google Scholar 

  • Davies P (1983) Neurochemical aspects of Alzheimer's disease. TIPS [Suppl] 4:98–99

    Google Scholar 

  • Drachman DA (1982) Aging and dementia: insights from the study of anticholinergic drugs. In: Katzman R (ed) Biological aspects of Alzheimer's disease. Banbury Reports, vol 15. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 363–369

    Google Scholar 

  • Drachman DA, Sahakian BJ (1980) Memory and cognitive function in the elderly: a preliminary trial of physostigmine. Arch Neurol 37:674–675

    Google Scholar 

  • Extance K, Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73:363–371

    CAS  PubMed  Google Scholar 

  • Herz A, Holzhauser H, Teschemacher H (1967) Central nicotine-and muscarine- like properties of cholinomimetic drugs with regard to their lipid solubility. Ann NY Acad Sci 142:21–26

    Google Scholar 

  • Meltzer LT, Rosecrans JA (1981) Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors. Psychopharmacology 75:383–387

    Google Scholar 

  • Overton DA (1974) Experimental methods for the study of state-dependent learning. Fed Proc 33:1800–1813

    Google Scholar 

  • Overton DA (1982) Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm. Psychopharmacology 76:385–395

    Google Scholar 

  • Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE (1977) Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 34:247–265

    Google Scholar 

  • Salamone JD, Lalies MD, Channell SL, Iversen SD (1986) Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology 88:467–471

    Google Scholar 

  • Schechter MD, Rosecrans JA (1972a) Atropine antagonism of arecoline-cued behavior in the rat. Life Sci 11:519–523

    Google Scholar 

  • Schechter MD, Rosecrans JA (1972b) Effect of mecamylamine on discrimination between nicotine- and arecoline-produced cues. Eur J Pharmacol 17:179–182

    Google Scholar 

  • Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York London

    Google Scholar 

  • Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413–419

    MathSciNet  MATH  Google Scholar 

  • Stolerman IP, Shine PJ (1985) Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982–1983. Psychopharmacology 86:1–11

    Google Scholar 

  • Visscher FE, Seay PH, Tazelaar AP Jr, Veldkamp W, Vanderbrook MJ (1954) Pharmacology of Pamine bromide. J Pharmacol Exp Ther 110:188–204

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, M., Costa, L., Shearman, G.T. et al. Discriminative stimulus properties of muscarinic agonists. Psychopharmacology 93, 139–145 (1987). https://doi.org/10.1007/BF00179923

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00179923

Key words

Navigation